Amebiasis | India| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


  • Amebiasis

    Among the issues that contribute to complicating the diagnosis and management of amebic infections are the varied clinical presentations, varied illness course in different communities, difficulties in diagnosis, and unavailability of medical resources in the developing world. Controversy surrounds the distinction between E histolytica and Entamoeba dispar infections. An integrated diagnostic-therapeutic approach is warranted to help address these complexities and provide the best patient management. Amebiasis is a parasitic disease of worldwide public health importance

  • Amebiasis

    Entamoeba histolytica is currently estimated to cause about 50 million infections worldwide every year, with an annual death rate of over 100,000. While the majority of infected persons remain asymptomatic cyst carriers, in a few the infection progresses to clinical illness. This observed disparity has remarkably affected the estimates of the global prevalenceand the treatment and management of the infection.

  • Amebiasis

    For symptomatic intestinal infection and extraintestinal disease, treatment with metronidazole or tinidazole should be followed by treatment with iodoquinol or paromomycin. Most patients have a gradual illness onset days or weeks after infection. Symptoms include cramps, watery or bloody diarrhea, and weight loss and may last several weeks.

High Impact List of Articles

Conference Proceedings